Reply to Zhou and Wu, "be careful with adverse events caused by cefoperazone-sulbactam"

Jien Wei Liu, Yen Hsu Chen, Wen Sen Lee, Jung Chung Lin, Ching Tai Huang, Hsi Hsun Lin, Yung Ching Liu, Yin Ching Chuang, Hung Jen Tang, Yao Shen Chen, Wen Chien Ko, Min Chi Lu, Fu Der Wangn

Research output: Contribution to journalLetter

Original languageEnglish
Article numbere02028
JournalAntimicrobial Agents and Chemotherapy
Volume64
Issue number2
DOIs
Publication statusPublished - Jan 27 2020

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Liu, J. W., Chen, Y. H., Lee, W. S., Lin, J. C., Huang, C. T., Lin, H. H., Liu, Y. C., Chuang, Y. C., Tang, H. J., Chen, Y. S., Ko, W. C., Lu, M. C., & Wangn, F. D. (2020). Reply to Zhou and Wu, "be careful with adverse events caused by cefoperazone-sulbactam". Antimicrobial Agents and Chemotherapy, 64(2), [e02028]. https://doi.org/10.1128/AAC.02028-19